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Abstract
Primary cardiac angiosarcoma is a rare and aggressive tumor with a high incidence of metastatic spread (up to
89%) at the time of diagnosis, which restricts the indication for surgical resection to a small number of patients.
We report the case of a 50-year old Caucasian woman with non-metastatic primary right atrial angiosarcoma, who
underwent successful surgical excision of the tumor (with curative intent) and reconstruction of the right atrium
with a porcine pericardial patch. However, after a symptom-free survival of five months the patient presented with
bone and liver metastases without evidence of local tumor recurrence.
Introduction
Angiosarcomas, although rare, are the most common
primary malignant neoplasms of the heart [1,2].
Although symptoms are often nonspecific and absent
for a long time, primary cardiac angiosarcomas (PCAs)
may present abruptly at which point there is often
already metastatic spread [2,3]. This restricts the indica-
tion for surgical resection to a small number of patients.
In this report we describe the case of a 50-year old
Caucasian woman with non-metastatic primary right
atrial angiosarcoma, who underwent successful surgical
excision of the tumor and reconstruction of the right
atrium with a porcine pericardial patch. Surgical resec-
tion was performed with curative intent and resection
m a r g i n sw e r ef r e eo ft u m o rc e l l s .H o w e v e r ,a f t e ra
symptom-free survival of five months the patient pre-
sented with bone and liver metastases without evidence
of local tumor recurrence.
Case report
A 50-year old female presented with shortness of breath,
chest and shoulder pain, and pericardial effusion. Peri-
cardiocentesis yielded 950 ml of pericardial fluid, which
was sent for biochemical, microbiological, and cytologi-
cal analysis. The diagnosis was inconclusive and she was
treated for presumed idiopathic recurrent pericarditis
with prednisone. Five months later she presented with
clinical signs of subacute cardiac tamponade. After peri-
cardiocentesis she quickly recovered, however, pericar-
dial fluid analysis again remained inconclusive. Three
months after this second episode transthoracic echocar-
diography (TTE) revealed a tumor in the right atrium.
The patient was then referred to our institution for
further evaluation.
A chest X-ray (Figure 1A) showed enlargement of the
right atrial border and an electrocardiogram showed
normal sinus rhythm with a heart rate of 87 beats per
minute.
Transthoracic (TTE) and transesophageal echocardio-
graphy (TEE) confirmed pericardial effusion, and
showed a giant mass (51 × 44 mm) that infiltrated the
right atrial free wall and that protruded into the right
atrium (Figure 1B). Left ventricular function was normal
and there were no valvular abnormalities.
Coronary angiography of the right coronary artery
(Figure 1C) showed two right atrial branches with sev-
eral small areas of abnormal contrast enhancement,
representing new vessel formation feeding the tumor
("tumor blush”). Right heart catheterization revealed
normal right heart and pulmonary artery pressures and
showed no signs of obstruction of blood flow in the
superior and inferior vena cava, in the right atrium and
ventricle, or in the pulmonary artery.
Fluorodeoxy-glucose-18 - positron emission tomogra-
phy - computer tomography (FDG-PET-CT) scanning
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and revealed hypermetabolic uptake of FDG in the right
atrium, consistent with malignancy. No metastatic
spread to any other organs was seen.
Cardiovascular magnetic resonance imaging (MRI) (Fig-
ure 1E) and CT (Figure 1F) showed a large excentric and
inhomogenous tumor (74 × 64 × 53 mm) in the right
atrial free wall, protruding into the right atrium, com-
pressing the right atrial appendage, and extending into
the wall of the superior vena cava. The tumor was in
close proximity to the ascending aorta and extended into
the right atrioventricular groove, but did not involve the
right coronary artery, the right ventricle, or the annulus
of the tricuspid valve. Pericardial effusion was identified
around the tumor, right atrium, and right ventricle.
CT, MRI, and PET did not reveal any positive lymph
nodes or mediastinal or lung involvement. MRI of the
brain did not show any cerebral metastases and a nor-
mal mammogram excluded primary breast cancer.
Twenty-two days after the initial diagnosis the patient
underwent surgical excision of the tumor (Figure 2A).
Histologic examination of a frozen section during sur-
gery revealed that the tumor was malignant (most likely
a type of sarcoma). The tumor was resected successfully
with curative intent. First, the tumor was dissected from
the base of the ascending aorta. Second, the right atrium
was opened and the tumor was dissected with a broad
margin from the superior vena cava and the septum
down to the annulus of the tricuspid valve. A free mar-
gin remained above the annulus for reconstruction.
Figure 1 Preoperative imaging of primary right atrial angiosarcoma. A. The chest X-ray shows enlargement of the right atrial border (the
cardiothoracic ratio is 0.56). B. Transthoracic echocardiography (TTE) (two chamber view of the right heart); confirms pericardial effusion, and
shows a giant mass (51 × 44 mm) that infiltrates the right atrial free wall and that protrudes into the right atrium (red arrows). C. Contrast
angiogram of the right coronary artery (right anterior oblique projection) showing the right coronary artery and two right atrial branches (red
arrowheads) with several small areas of abnormal contrast enhancement, characteristic of a “tumor blush” (red arrows) (representing new vessel
formation feeding the angiosarcoma). D. FDG (fluorodeoxy-glucose-18) PET-CT scanning (transverse section, four chamber view) to assess
metabolic activity reveals hypermetabolic uptake of FDG in the right atrium (red arrow), consistent with malignancy. Paravertebrally, there is
physiologic brown fat activity. E. Turboflash 2D cine MRI (sagittal section, through the superior vena cava); large inhomogenous tumor in the
lateral wall of the right atrium (diameter of approximately 74 mm), extending into the wall of the superior vena cava (red arrow). F. CT
(reconstruction along the cardiac axis); large inhomogenous tumor in the lateral wall of the right atrium, protruding into the right atrium (64 ×
53 mm), without invasion of the right ventricular wall (red arrows). A, coronal plane; L, sagittal plane; H, horizontal plane; RA, right atrium; RV, right
ventricle; SVC, superior vena cava.
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right coronary artery, which was adherent to, but not
invaded by the tumor, was successfully dissected. All
branches feeding the tumor were clipped. The tumor
was successfully resected with a tumor-free margin on
each side. Finally, the right atrium was reconstructed
with a porcine pericardial patch.
The resected tumor was 100 × 70 × 45 mm in size
(Figure 2B). Histopathologic examination (Figure 3A)
showed a hemorrhagic and necrotic malignant tumor
that invaded atrial myocardium and epicardium. The
tumor contained solid areas and anastomosing vascular
spaces lined by spindle-shaped cells with pleomorphic
hyperchromatic nuclei and brisk mitotic activity. The
resection margins were free of tumor cells, but the
tumor extended to the epicardial surface with a small
margin of less than 1 mm. Immunohistochemically, the
tumor cells were positive for the endothelial markers
factor VIII-related protein, CD31 and CD34 (Figure 3B),
whereas reactivity to podoplanin, smooth muscle actin,
desmin, S100 protein, keratins, and EMA was negative.
These findings confirmed the diagnosis of primary right
atrial angiosarcoma.
Postoperative recovery was uneventful and the patient
was discharged on the eleventh postoperative day. A fol-
low-up CT-scan after three months revealed no tumor
recurrence. After a symptom-free survival of five months
the patient unfortunately presented with bone and liver
metastases without evidence of local tumor recurrence.
Both chemotherapy and irradiation were started.
Discussion
Primary cardiac tumors are rare, with an incidence at
autopsy from 0.0017% to 0.033% [4]. Metastases are by
far the most common cardiac neoplasms; they are 40
times more prevalent than primary cardiac tumors [1].
Figure 2 Macroscopic pathology photographs of primary right atrial angiosarcoma. A. Intraoperative photograph; initial view of the right
atrial tumor during surgery. B. Macroscopic photograph; broadly resected large tumor of the right atrial free wall as seen from inside the right
atrium. The tumor protrudes into the right atrium (tumor size: 100 × 70 × 45 mm).
Figure 3 Microscopic pathology photographs of primary right atrial angiosarcoma. A. Histologic photomicrograph (HE stain, original
magnification 20×); the tumor consists of spindle-shaped cells with pleomorphic nuclei lining anastomosing vascular spaces. Mitotic figures and
areas of hemorrhage and necrosis can also be found. These findings support the diagnosis of angiosarcoma. The lower left corner shows
myocardial invasion with tumor cells. B. Immunohistochemistry photomicrograph (CD31 stain, original magnification 40×); the tumor cells are
positive for the endothelial marker CD31, which confirms the vascular nature of the tumor.
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are benign, with myxoma accounting for up to half of
cases. The remaining 25% of primary cardiac tumors are
malignant, and one-third of those are angiosarcoma [5].
Other primary malignant cardiac tumors include rhab-
domyosarcoma, osteosarcoma, leiomyosarcoma, undif-
ferentiated sarcoma, and primary cardiac lymphoma [1].
Primary cardiac angiosarcomas (PCAs) have a tendency
to occur in the third to fifth decade and are more com-
mon in males [2,3,6]. Ninety percent of the angiosarco-
mas are located in the right atrium [6]. The lateral (free)
wall of the right atrium is the most common site, the
septum being spared in most cases [2,3,6].
PCAs may present abruptly with a fulminant clinical
course. The clinical signs and symptoms are often non-
specific. Symptoms are often absent for a long time and
are related to the cardiac location of the tumor, its size,
the degree of myocardial involvement, and the presence
of metastases [4,7,8]. Because of the propensity of the
tumor to involve the right atrium and pericardium,
patients may present with right-sided heart failure,
superior vena cava obstruction, and recurrent pericardial
effusions or cardiac tamponade [2,8,9]. Dyspnea is the
most common presenting symptom; additional symp-
toms include atypical chest pain, hemoptysis, orthopnea,
and nonspecific symptoms such as nausea, emesis, fever,
and anorexia [7].
PCAs are aggressive tumors, with metastasis found in
66 to 89% of patients at the time of diagnosis [2,3].
PCAs most commonly metastasize to the lungs, but also
occasionally to lymph nodes, bone, liver, brain, bowel,
spleen, adrenal glands, pleura, diaphragm, kidneys, thyr-
oid, and skin [10].
The differential diagnosis of a right atrial mass
includes benign entities such as myxoma and thrombus
and malignant causes such as metastatic involvement of
the heart, primary cardiac angiosarcoma and other sar-
comas, pericardial mesothelioma, and primary cardiac
lymphoma [11].
Echocardiography has become the primary diagnostic
technique because of its high degree of accuracy, non-
invasiveness, and cost effectiveness [12]. Besides echocar-
diography, CT, MRI, and PET can be of benefit in the
diagnostic work-up [13,14]. These imaging modalities are
particularly helpful in defining the extent to which the
cardiac tumor infiltrates surrounding structures and
when assessing the patient for metastases to other organs.
CT and MRI can both show tumor infiltration of the
myocardium and direct extension into the pericardium
[9]. On CT angiosarcomas appear as irregular lobulated
low-attenuation masses that frequently extend to involve
the adjacent pericardium and vessels [11]. Cardiac MRI
enables the most comprehensive imaging assessment
of cardiac neoplasms. In contrast to TTE, cardiac
MRI provides improved soft-tissue contrast, tissue
characterization, and assessment of mediastinal and lung
involvement by the tumor [11]. The addition of imaging
with a gadolinium-based contrast agent allows an assess-
ment of the extent of tumor vascularity and further
improves the differentiation from surrounding structures
[11]. The presence of large blood filled spaces might
account for the “cauliflower appearance” (local nodular
areas of increased signal intensity interspersed with areas
of intermediate signal intensity) [15].
Cytologic examination on fluid obtained by pericardio-
centesis rarely yields a conclusive diagnosis [16]. In case
of negative pericardial fluid cytology, tissue specimens
can be obtained by thoracotomy, TTE or CT guided
biopsy [8], or TEE guided transvenous endomyocardial
biopsy [17]. However, biopsy is frequently non-diagnos-
tic and carries a considerable risk of cardiac rupture
because the right atrial wall is thin [8].
Histopathology defines angiosarcoma as a malignant
tumor whose cells display endothelial differentiation [2].
Microscopically, tumor differentiation is reflected by for-
mation of irregular anastomozing vascular spaces. Poorly
differentiated angiosarcomas show solid growth. Tumor
cells can still have an endothelial morphology or can be
spindle-shaped with malignant appearing, hyperchro-
matic nuclei [18]. Mitotic figures and areas of hemor-
rhage and necrosis are always present [18]. The
diagnosis of cardiac angiosarcoma can be confirmed by
additional immunohistochemical staining for endothelial
markers, of which CD31 and factor VIII-related protein
are most specific [19].
Appropriate evidence-based treatment guidelines have
not been established because of the rarity of the tumor
[20]. Surgical resection is indicated when no evidence of
metastasis exists and when myocardial resection is
reparative [13]. The surgical approach is often difficult
s i n c eP C A su s u a l l ya r es ol a r g ea tt h et i m eo fd i a g n o s i s
that complete resection cannot be achieved. However,
even incomplete resection may provide substantial
symptom-free survival [21]. In case of extensive infiltra-
tion of the right heart requiring partial cardiectomy for
complete surgical resection, functional reconstruction
may be achieved with a cavopulmonary shunt or Fon-
tan-type operation, excluding the right heart from the
circulation [22]. Anatomic and functional reconstruction
of the right heart may also be accomplished with a right
atrial patch [13], as we have also shown in this report.
Chemotherapy and irradiation were reported not to
improve survival [7] and their use is usually limited due
to the poor physical condition of the patient. However,
a multidisciplinary approach involving surgery, irradia-
tion, adjuvant chemotherapy, and immunotherapy, using
interleukin-2, may offer hope for increased survival in
selected patients [23]. Cardiac transplantation has been
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come [24]. There is no evidence that cardiac transplan-
tation improves the overall poor prognosis of these
patients. Moreover, there is concern about enhancing
tumor growth in the setting of immunosuppressive
drugs [25].
The prognosis of cardiac angiosarcoma is universally
poor: survival ranges from six to nine months, regardless
of the treatment chosen [7]. Death results from infiltra-
tion of the myocardium, cardiac tamponade, obstruction
of flow, and/or distant metastases.
Conclusions
The high frequency of metastatic spread at the time of
diagnosis (up to 89%) combined with the aggressive
behaviour of PCAs usually results in disappointing treat-
ment outcomes. However, early detection and aggressive
treatment may lead to a more favorable outcome and
may extend survival beyond one year. Therefore, when a
patient presents with (recurrent) pericardial effusions or
when a right-sided cardiac mass is detected, there
should always be a high level of suspicion for PCA.
Newer imaging modalities, including CT and MRI, can
help define the exact location and extent of the tumor
and aid in the planning of surgical resections. Due to
the rarity of PCA treatment options are at this point
limited and not evidence-based.
This case of primary right atrial angiosarcoma in a 50-
year old Caucasian woman highlights its nonspecific clini-
cal presentation, the diagnostic delay, the broad spectrum
of diagnostic imaging modalities, and the rapid and
aggressive natural course of cardiac angiosarcomas.
Although successful surgical resection of PCA (with cura-
tive intent) in the apparent absence of metastatic spread
is possible, there may be micrometastases at the time of
diagnosis and surgery. In that case, an apparently curative
(local) surgical resection may provide substantial symp-
tom-free survival, but it has little influence on the rapid
and aggressive natural course of PCA.
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